Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin for haemorrhagic stroke in patients taking antiplatelet therapy
ISRCTN67038373Phase 2Completed
- Sponsor
- University of Nottingham
- Start
- Nov 2018
- Modality
- Small Molecules, Peptides
01
Overview
Phase 2, randomised trial in intracerebral hemorrhage (ICH) and brain hemorrhage (ICH) comparing Desmopressin with Placebo (2 arms). Primary endpoint: Feasibility of randomisation, treatment delivery, and follow-up. Started Nov 2018; status: completed.
02
Drugs
desmopressin
03
Conditions
intracerebral hemorrhage (ICH)brain hemorrhage (ICH)
Beyond the preview
Go deeper on ISRCTN67038373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN67038373.